PMID- 28786001 OWN - NLM STAT- MEDLINE DCOM- 20180606 LR - 20230722 IS - 1868-8500 (Electronic) IS - 1868-8497 (Print) IS - 1868-8497 (Linking) VI - 8 IP - 5-6 DP - 2017 Dec TI - Maternal Resveratrol Treatment Reduces the Risk of Mammary Carcinogenesis in Female Offspring Prenatally Exposure to 2,3,7,8-Tetrachlorodibenzo-p-Dioxin. PG - 286-297 LID - 10.1007/s12672-017-0304-7 [doi] AB - 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) presents adverse effects on breast development/carcinogenesis. This study aimed to identify the ability of resveratrol (Res) to modify the adverse effects of TCDD in a female offspring. Pregnant female Wistar rats were allocated into four groups: TCDD, TCDD + Res, Res, and control. TCDD (1 mug/kg) was orally administered as a single dose on gestational day (GD) 15, and Res was orally administered during GD10-21 and lactation at a dose of 20 mg/kg/day. Female offsprings were euthanized on a specific postnatal day (PND) for hormonal analysis (PND 22, 48-51), vaginal opening (PND 30-48), and mammary gland morphology (PND 22). Other females received two doses of N-nitroso-N-methylurea (MNU, 50 mg/kg) on PNDs 22 and 51 and were euthanized on PND 24 (Ki-67, ER-alpha and apoptosis indexes or molecular analysis) or PND 180 (tumor assay). TCDD exposure altered the development of the mammary structure while these alterations were partially improved by maternal Res. Two days after first MNU administration, some genes associated with apoptosis were altered in the mammary tissue from the TCDD group (Bax and Caspase 3 down- and Bcl-2 upregulated) but were also partially reestablished by maternal Res. Mammary gland bcl-2 and bcl-xl proteins expression was increased while the apoptosis index was reduced by TCDD exposure but restored by maternal Res. An increase in number of mammary tumors was observed in female offspring from the TCDD group compared to the other groups. The results indicate that most mammary changes induced in female offspring through TCDD exposure or after MNU administrations were reduced by maternal resveratrol treatment. FAU - de Lima E Silva, Tassia C AU - de Lima E Silva TC AD - Departamento de Enfermagem, Centro Academico de Vitoria, UFPE- Universidade Federal do Pernambuco (UFPE), Vitoria de Santo Antao, PE, 55608-680, Brazil. AD - Departamento de Patologia, Faculdade de Medicina de Botucatu, Universidade Estadual Paulista (UNESP), Botucatu, SP, 18610-307, Brazil. FAU - da Silveira, Livia T R AU - da Silveira LTR AD - Departamento de Morfologia, Instituto de Biociencias de Botucatu, Universidade Estadual Paulista (UNESP), Botucatu, SP, 18618-689, Brazil. FAU - Fragoso, Mariana F AU - Fragoso MF AD - Departamento de Patologia, Faculdade de Medicina de Botucatu, Universidade Estadual Paulista (UNESP), Botucatu, SP, 18610-307, Brazil. FAU - da Silva, Flavia R M AU - da Silva FRM AD - Departamento de Patologia, Faculdade de Medicina de Botucatu, Universidade Estadual Paulista (UNESP), Botucatu, SP, 18610-307, Brazil. FAU - Martinez, Meire F AU - Martinez MF AD - Departamento de Morfologia, Instituto de Biociencias de Botucatu, Universidade Estadual Paulista (UNESP), Botucatu, SP, 18618-689, Brazil. FAU - Zapaterini, Joyce R AU - Zapaterini JR AD - Departamento de Patologia, Faculdade de Medicina de Botucatu, Universidade Estadual Paulista (UNESP), Botucatu, SP, 18610-307, Brazil. FAU - Diniz, Odair H G AU - Diniz OHG AD - Departamento de Morfologia, Instituto de Biociencias de Botucatu, Universidade Estadual Paulista (UNESP), Botucatu, SP, 18618-689, Brazil. FAU - Scarano, Wellerson R AU - Scarano WR AD - Departamento de Morfologia, Instituto de Biociencias de Botucatu, Universidade Estadual Paulista (UNESP), Botucatu, SP, 18618-689, Brazil. FAU - Barbisan, Luis F AU - Barbisan LF AD - Departamento de Morfologia, Instituto de Biociencias de Botucatu, Universidade Estadual Paulista (UNESP), Botucatu, SP, 18618-689, Brazil. barbisan@ibb.unesp.br. LA - eng PT - Journal Article DEP - 20170807 PL - United States TA - Horm Cancer JT - Hormones & cancer JID - 101518427 RN - 0 (Antineoplastic Agents, Phytogenic) RN - 0 (Hormones) RN - 0 (Polychlorinated Dibenzodioxins) RN - 0 (Stilbenes) RN - 0 (Teratogens) RN - Q369O8926L (Resveratrol) SB - IM MH - Animals MH - Antineoplastic Agents, Phytogenic/*pharmacology MH - Breast Neoplasms/*etiology/pathology/prevention & control MH - Cell Transformation, Neoplastic/chemically induced/metabolism/pathology MH - Disease Models, Animal MH - Female MH - Hormones/blood/metabolism MH - Male MH - Maternal Exposure/*adverse effects MH - Polychlorinated Dibenzodioxins/*adverse effects MH - Pregnancy MH - *Prenatal Exposure Delayed Effects MH - Rats MH - Resveratrol MH - Stilbenes/*administration & dosage MH - Teratogens/*toxicity MH - Tumor Burden PMC - PMC10355987 COIS- The authors declare that they have no conflict of interest. EDAT- 2017/08/09 06:00 MHDA- 2018/06/07 06:00 PMCR- 2017/08/07 CRDT- 2017/08/09 06:00 PHST- 2017/05/24 00:00 [received] PHST- 2017/07/31 00:00 [accepted] PHST- 2017/08/09 06:00 [pubmed] PHST- 2018/06/07 06:00 [medline] PHST- 2017/08/09 06:00 [entrez] PHST- 2017/08/07 00:00 [pmc-release] AID - 10.1007/s12672-017-0304-7 [pii] AID - 304 [pii] AID - 10.1007/s12672-017-0304-7 [doi] PST - ppublish SO - Horm Cancer. 2017 Dec;8(5-6):286-297. doi: 10.1007/s12672-017-0304-7. Epub 2017 Aug 7.